Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice.

导出 LinkOut

翻译打印收藏纠错

作者： Tomohide,Hori ^[1] ; Shinji,Uemoto ; Lindsay B,Walden ; Feng,Chen ; Ann-Marie T,Baine ; Toshiyuki,Hata ; Takayuki,Kogure ; Justin H,Nguyen

作者单位： Department of Neuroscience, Mayo Clinic in Florida; Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto. ^[1]

关键词 comatose hepatic encephalopathy liver transplantation matrix metalloproteinase tissue inhibitor of metalloproteinases

DOI 10.1111/hepr.12161

PMID 23672352

发布时间 2020-09-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览14

Hepatology research

2014年44卷6期

651-62页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice.

Hepatology research

相似文献

Hepatology research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice.

Hepatology research

相似文献

Hepatology research

相关期刊

检索历史清除